Publication | Closed Access

MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial–mesenchymal transition

Tumor BiologyHepatologyMedicineEpithelial–mesenchymal TransitionPathologyCancer Cell BiologyEpithelial-mesenchymal InteractionsHepatocellular Carcinoma ProgressionLiver CancerCancer BiologyCell BiologyHepatocellular CarcinomaCancer ResearchCancer Growth